T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
CRA International
CRAI
$1.07B
| $343K | ﹤0.01% |
3,401
+153
| +5% | +$16.1K |
|
2277
Editas Medicine
EDIT
$432M
| $342K | ﹤0.01% |
43,792
+8,099
| +23% | +$69.5K |
|
2278
Evolus
EOLS
$530M
| $342K | ﹤0.01% |
37,393
+791
| +2% | +$7.09K |
|
|
DO
2279
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $342K | ﹤0.01% |
23,251
+2,648
| +13% | +$40.4K |
|
2280
Fluence Energy
FLNC
$2.44B
| $339K | ﹤0.01% |
14,739
+1,820
| +14% | +$46.9K |
|
2281
Simulations Plus
SLP
$370M
| $338K | ﹤0.01% |
8,089
-1,116
| -12% | -$50.6K |
|
2282
TTEC Holdings
TTEC
$77.4M
| $338K | ﹤0.01% |
12,889
+617
| +5% | +$18.5K |
|
2283
Mirion Technologies
MIR
$3.88B
| $336K | ﹤0.01% |
44,847
+4,261
| +10% | +$33.6K |
|
2284
Healthcare Services Group
HCSG
$1.45B
| $335K | ﹤0.01% |
32,092
+4,661
| +17% | +$58K |
|
2285
Rio Tinto
RIO
$160B
| $331K | ﹤0.01% |
5,200
| – | – |
|
2286
Revolve Group
RVLV
$1.72B
| $330K | ﹤0.01% |
24,207
+805
| +3% | +$12.8K |
|
|
CCRN
2287
DELISTED
Cross Country Healthcare
CCRN
| $328K | ﹤0.01% |
13,219
+453
| +4% | +$11.4K |
|
2288
FIGS
FIGS
$2.47B
| $328K | ﹤0.01% |
55,543
+2,691
| +5% | +$17.9K |
|
2289
Intapp
INTA
$3.16B
| $328K | ﹤0.01% |
9,766
-247,820
| -96% | -$9.05M |
|
2290
Anavex Life Sciences
AVXL
$303M
| $325K | ﹤0.01% |
49,509
+6,140
| +14% | +$48.9K |
|
2291
Outset Medical
OM
$79.9M
| $325K | ﹤0.01% |
1,989
+65
| +3% | +$15.3K |
|
2292
LSI Industries
LYTS
$912M
| $324K | ﹤0.01% |
20,391
-1,911
| -9% | -$26.7K |
|
2293
National Presto Industries
NPK
$987M
| $323K | ﹤0.01% |
4,455
+581
| +15% | +$43.9K |
|
|
RYZ
2294
Ryerson Holding Corp
RYZ
$1.5B
| $323K | ﹤0.01% |
11,090
+1,026
| +10% | +$34.8K |
|
2295
Triumph Financial Inc
TFIN
$1.87B
| $323K | ﹤0.01% |
4,976
+353
| +8% | +$23.3K |
|
2296
TPG
TPG
$8.86B
| $322K | ﹤0.01% |
10,659
+843
| +9% | +$24.6K |
|
2297
HealthStream
HSTM
$849M
| $321K | ﹤0.01% |
14,848
+665
| +5% | +$14.7K |
|
|
PSTL
2298
Postal Realty Trust
PSTL
$701M
| $320K | ﹤0.01% |
23,672
+6,751
| +40% | +$97.9K |
|
2299
Shutterstock
SSTK
$217M
| $319K | ﹤0.01% |
8,362
+650
| +8% | +$29.1K |
|
2300
Banc of California
BANC
$3.11B
| $318K | ﹤0.01% |
25,661
+1,275
| +5% | +$16.2K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.